PMLS Virtual Series 2021 – Precision Oncology Fall

On Demand Now Click Here

Oct 5, 2021

Precision Oncology had a tremendous boost with the 2015 roll-out of the Precision Medicine Initiative.  What started with a focus on next generation gene sequences for the cancer genome has blossomed into a full set of tools for assaying solid and liquid tumors and the consequent development of analytical assays, analysis software platforms, and precision therapies – biologics, vaccines, and small-molecules.

Nowhere has precision oncology been more useful than in developing innovative technologies for tumor heterogeneity.  Precision Oncology has benefited from, first, precision sequencing of populations of cells and, second, through development of small-molecule drugs and biologics that alone or in combination have boosted the efficacy of therapies.  Further, innovations in cell-based therapies (NK cell, CAR-T cell therapies) are in clinical trials; in fact, CAR-T cell therapies have been approved by FDA for selected cancer cases.

Come join us for the Precision Oncology Virtual Summit to hear from leaders in academia, biotech, pharma, diagnostics, clinical research, healthcare, and regulatory bodies on this topic!

With all this innovation in full swing, you cannot miss the line-up of speakers who will address these topics and more:

  • Clinical data in the era of Precision Oncology
  • Biomarker/Genetics/Genomics Platforms
  • Clinical and gene-based assays
  • Novel therapies for cancer – biologics, vaccines, small molecules, and combination therapies
  • Cell-based therapies and scale-up
  • Identification and stratification strategies for oncology clinical trials
  • Positioning drugs tied to pharmacogenetics for coverage by payers
  • Tracking and evaluating data through telehealth for rapid collections of clinical trial data

Who should attend:

  • Executives and Decision Makers – CEOs, CTOs, CMOs, and CSOs
  • Leaders in clinical genomics, biomarkers, assays
  • Clinical trial planning and operations
  • Clinical Research, Development, Translational Medicine
  • Practicing Clinicians
  • Genomics/Genetics Analysts
  • Regulatory Leaders in Government and Business Affairs groups
  • Economic Planners and Forecasters
  • Marketing Leaders
  • Business Development Managers
  • Biotech and Biomedical technology researchers
  • Government and public support agencies